The NOTCH1 and SF3B1 mutations are predictors of shorter survival in patients with relapsed or refractory CLL. These mutations are also predictors of shorter survival in patients who have been newly diagnosed with CLL.
Learn more about chromosomal testing and CLL.
Editor's Recommendations
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Karl J. D'Silva. Fast Five Quiz: Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) - Medscape - Jun 23, 2020.
Comments